Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

Share Price is delayed by 15 minutes
Get Live Data
2,020.00    -52.00 (-2.51%)
Bid:
2,008.00
Ask:
2,016.00
Spread: 8.00 (0.398%)
Market Cap: £1.34b
GNS Live PriceLast checked at - London Stock Exchange

Intraday Genus Share Chart

Director/PDMR Shareholding

10 Sep 2010 14:00

RNS Number : 4952S
Genus PLC
10 September 2010
 

10 September 2010

FOR IMMEDIATE RELEASE 

 

 

GENUS plc

('Genus' or 'the Company')

 

Directors' and PDMRs' Share Options

 

Genus announces that conditional nil-cost share options were granted under the Genus 2004 Performance Share Plan ("the Plan") today to John Worby, Group Finance Director, as to 37,680 ordinary shares of 10 pence each in the Company ("Shares"), to Ian Biggs, Head of Global Product & Business Strategy, as to 27,404 Shares, to Thomas Philip Acton, Chief Operating Officer of Europe & The Far East as to 27,404 Shares, to Bill Christianson, Chief Operating Officer of The Americas, as to 24,418 Shares, to Ian Farrelly, Group Company Secretary & General Counsel as to 21,923 Shares and to David Crosby, Group Financial Controller, as to 19,457 Shares.

 

These options are subject to performance conditions which relate to growth in the Company's earnings per share over a three year period and which trigger vesting on an incremental basis.

 

John Worby's direct shareholding stands at 10,000 Shares representing 0.017% of the issued share capital of the Company. In addition, he is the beneficial owner of 166,220 nil-cost options. 

 

Ian Biggs' direct shareholding stands at 3,375 Shares representing 0.006% of the issued share capital of the Company. In addition, he is the beneficial owner of 143,894 conditional shares and nil-cost options. 

 

Thomas Philip Acton's direct shareholding stands at 21,104 Shares representing 0.035% of the issued share capital of the Company. In addition, he is the beneficial owner of 136,589 conditional shares and nil-cost options.

 

Bill Christianson has no direct shareholding in the Company and is the beneficial owner of 36,500 nil-cost share options and 34,693 market value share options.

 

Ian Farrelly has no direct shareholding in the Company and is the beneficial owner of 92,200 conditional shares and nil-cost share options.

 

David Crosby has no direct shareholding in the Company and is the beneficial owner of 38,861 nil-cost share options and 16,373 market value share options. 

 

 

For further information please contact:

 

Cara Crichton

Company Secretarial Assistant

Genus plc

 

Tel: 01256 345996

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSURORRRWAKAAR
Date   Source Headline
26th Nov 20104:27 pmRNSHolding(s) in Company
11th Nov 20103:33 pmRNSResult of AGM
11th Nov 20107:00 amRNSAGM and IMS
29th Oct 20102:30 pmRNSTotal Voting Rights
28th Oct 20107:00 amRNSStrategic Progress in India
27th Oct 20102:30 pmRNSAnnual Information Update
14th Oct 201010:00 amRNSAnnual Financial Report and AGM Meeting
30th Sep 20103:30 pmRNSTotal Voting Rights
27th Sep 20102:30 pmRNSDirector/PDMR Shareholding
22nd Sep 20103:16 pmRNSAdditional Listing
22nd Sep 20102:49 pmRNSDirector/PDMR Shareholding
15th Sep 20102:50 pmRNSDirector/PDMR Shareholding
13th Sep 201011:00 amRNSDirector/PDMR Shareholding
10th Sep 20102:00 pmRNSDirector/PDMR Shareholding
7th Sep 20107:01 amRNSBoard Change
7th Sep 20107:00 amRNSPreliminary Results
30th Jul 20102:00 pmRNSBlocklisting Interim Review
5th Jul 20107:00 amRNSPre-Close Trading Statement
17th Jun 20102:30 pmRNSHolding(s) in Company
3rd Jun 20103:30 pmRNSDirector's Shareholding
12th May 20107:00 amRNSInterim Management Statement
30th Apr 20102:00 pmRNSTotal Voting Rights
19th Apr 20102:58 pmRNSHolding(s) in Company
7th Apr 20102:00 pmRNSHolding(s) in Company
1st Apr 20102:30 pmRNSDirector/PDMR Shareholding
2nd Mar 20103:00 pmRNSDirector/PDMR Shareholding
26th Feb 20109:17 amRNSHolding(s) in Company
25th Feb 20107:00 amRNSSenior Management Appointments
25th Feb 20107:00 amRNSInterim Results
22nd Feb 20103:33 pmRNSHolding(s) in Company
29th Jan 201010:00 amRNSBlocklisting 6 Monthly Return
26th Jan 20107:00 amRNSNotice of Results
14th Jan 20105:27 pmRNSHolding(s) in Company
4th Jan 20107:00 amRNSTotal Voting Rights
30th Nov 20094:00 pmRNSTotal Voting Rights
30th Nov 20092:00 pmRNSDirector/PDMR Shareholding
17th Nov 20094:20 pmRNSHolding(s) in Company
13th Nov 20092:00 pmRNSDirector/PDMR Shareholding
12th Nov 20093:25 pmRNSResult of AGM
12th Nov 20092:15 pmRNSAGM and Interim Management Statement
30th Oct 20092:00 pmRNSTotal Voting Rights
27th Oct 20092:00 pmRNSAnnual Information Update
9th Oct 20093:58 pmRNSAnnual Financial Report and AGM
30th Sep 20092:00 pmRNSTotal Voting Rights
28th Sep 20094:10 pmRNSDirector/PDMR Shareholding
16th Sep 20092:30 pmRNSDirector/PDMR Shareholding
15th Sep 20092:32 pmRNSDirector/PDMR Shareholding
10th Sep 20094:37 pmRNSDirector/PDMR Shareholding
10th Sep 20097:00 amRNSBovine Research And Development Success
10th Sep 20097:00 amRNSPreliminary Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.